Adaptimmune Therapeutics Plc Stock Widgets and Gadgets
| ADAP Stock | USD 0.61 0.02 3.39% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- ADAP Adaptimmune Therapeutics Plc
- Latest Adaptimmune Therapeutics plc Short Interest Up 8.7 percent in January - MarketBeat
- ADAP 0.61 0.02
- Low 0.58
- High 0.62
- Volume 964.3 K
- Alpha -0.2
- Beta 0.45
- Return On Equity -0.65
- Return On Asset -0.16
- Profit Margin (0.51) %
- Operating Margin 0.54 %
- Current Valuation 43.8 M
- Shares Outstanding 255.88 M
- Shares Owned By Insiders 0.37 %
- Shares Owned By Institutions 60.26 %
- Number Of Shares Shorted 5.76 M
- Price To Earning (7.73) X
- Price To Book 1.94 X
- Price To Sales 1.10 X
- Revenue 60.28 M
- Gross Profit (5.19 M)
- EBITDA (128.2 M)
- Net Income (113.87 M)
- Cash And Equivalents 199.67 M
- Cash Per Share 1.22 X
- Total Debt 25.23 M
- Debt To Equity 0.20 %
- Current Ratio 4.00 X
- Book Value Per Share 0.17 X
- Cash Flow From Operations (140.88 M)
- Short Ratio 4.71 X
- Earnings Per Share (0.17) X
- Price To Earnings To Growth 0.11 X
- Target Price 2.27
- Number Of Employees 449
- Beta 2.25
- Market Capitalization 155.4 M
- Total Asset 282.62 M
- Retained Earnings (1.02 B)
- Working Capital 134.76 M
- Current Asset 199.54 M
- Current Liabilities 22.66 M
- Net Asset 282.62 M
- Accumulation Distribution 62212.84
- Daily Balance Of Power 0.5
- Rate Of Daily Change 1.03
- Day Median Price 0.6
- Day Typical Price 0.6
- Price Action Indicator 0.02
- Period Momentum Indicator 0.02
Market Snapshot Widget Example
DAX Index Germany | 21,902 1.47 | |
Taiwan Weighted Taiwan | 23,317 0.67 | |
PSI 20 Stock Portugal | 6,534 0.05 | |
CROBEX Croatia | 3,462 0.05 | |
Budapest SE Hungary | 86,996 3.33 | |
IDX 30 Jakarta Indonesia | 402.44 3.13 | |
ISEQ 20 Price Ireland | 1,734 1.44 | |
NYSE Comp USA | 20,158 0.14 | |
Tel Aviv 35 Israel | 2,508 0.03 | |
Coreshares Index Tracker South Afric | 1,128 0.27 | |
IPC MEXICO Mexico | 52,752 2.29 | |
KL Technology Malaysia | 59.06 0.44 | |
IBEX 35 Index Spain | 12,731 1.55 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,920 3.41 | |
SPASX Dividend Opportunities Australia | 1,714 1.08 | |
HNX 30 Vietnam | 476.81 0.70 | |
Bucharest BET-NG Romania | 1,240 0.97 | |
AMS Small Cap Netherlands | 1,261 1.68 | |
Oslo Exchange Mutual Norway | 1,460 0.16 | |
BEL Small Belgium | 8,570 0.24 | |
Basic Materials Brazil | 5,461 1.33 | |
Swiss Leader Price Switzerland | 2,078 0.69 | |
Fondo Mutuo ETF Chile | 1,504 0.34 | |
Athens General Comp Greece | 1,544 1.79 | |
Stock Exchange Of Thailand | 1,262 1.92 | |
PX Prague Stock Czech Repub | 1,857 0.43 | |
THE PHILIPPINE STOCK Philippines | 6,242 0.62 | |
WIG 30 Poland | 3,134 2.65 | |
BIST Electricity Turkey | 484.80 1.56 |
Investing Ideas
In addition to having Adaptimmune Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Adaptimmune Therapeutics
Compare Adaptimmune Therapeutics To Peers
Additional Tools for Adaptimmune Stock Analysis
When running Adaptimmune Therapeutics' price analysis, check to measure Adaptimmune Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adaptimmune Therapeutics is operating at the current time. Most of Adaptimmune Therapeutics' value examination focuses on studying past and present price action to predict the probability of Adaptimmune Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adaptimmune Therapeutics' price. Additionally, you may evaluate how the addition of Adaptimmune Therapeutics to your portfolios can decrease your overall portfolio volatility.